Latest Conference Articles

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

For many physicians, “moral injury” may be actual issue

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma

The American Academy of Ophthalmology (AAO) is taking its annual meeting virtual amid the COVID-19 pandemic.

There are other mimickers of NTG that should be kept in mind

New products increase the chance of early diagnosis

New therapies on the horizon offer options for slowing progression

ICYMI: Yvonne Ou, MD, discusses her presentation on "Apps for the visually challenged," during the 2020 Glaucoma 360 annual meeting in San Francisco, California.

Novel technologies range from invasive to non-invasive approaches

Dale Heuer, MD discusses the importance of ophthalmologists identifying and providing more aggressive treatment care for patients with low/high risks of developing glaucoma.

Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.

ICYMI: Thomas Samuelson, MD,shares the key highlights from his presentation "Stents, trabs, and tubes: Decision-making in surgical glaucoma."

Dee Stephenson, MD, ABO, discusses the highlights of her presentation "Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA" during the 2020 ASCRS virtual meeting.